State Ledger
Company profile

ANAVEX LIFE SCIENCES CORP. CIK 1314052

Ticker
AVXL (Nasdaq)
Industry
Biological Products, (No Diagnostic Substances)
Headquarters
New York, NY 10111
Fiscal year end
2025 (FY)
Market Data
Close
$1.52
Change
+$0.04
Change %
2.36%
Volume
96,019

AVXL · trading date Oct 12, 2026 · previous close $1.49 · source: Alpaca (IEX feed, not consolidated full-market data).

Key Financials
Revenue
—
Net income
-$46.38M
Total assets
$103.82M
Total liabilities
$8.95M
Stockholders' equity
$94.87M
Cash & equivalents
$102.58M
Operating income
-$51.41M
Operating cash flow
-$39.04M
Capital expenditures
—

Fiscal year 2025, via 10-K/A filed 2026-08-28. A dash means this figure wasn't reported in the source filing under a field State Ledger recognizes - not that the value is zero.

Financial Performance
Operating margin
—
Net margin
—
Free cash flow
—
Free cash flow margin
—
Liabilities / assets
8.6%
Equity / assets
91.4%
CapEx / revenue
—
Operating cash flow / net income
0.84×

Derived from the fiscal year 2025 figures above. These metrics are mathematical calculations and do not represent a rating or assessment of the company.

Financial History
Fiscal yearRevenueNet incomeAssetsLiabilitiesEquity
2025 — -$46.38M $103.82M $8.95M $94.87M
2024 — -$43.00M $135.57M $15.30M $120.26M
2023 — -$47.51M $154.39M $12.53M $141.85M
2022 — -$47.98M $152.71M $10.21M $142.49M
2021 — -$37.91M $161.62M $10.80M $150.82M
Company Details
SIC code
2836
Active filer
Yes
Most recent SEC filing
Form DFAN14A
2026-09-18
Financials filed via
Form 10-K/A
filed 2026-08-28

"Most recent SEC filing" may differ from the filing used for the financial figures above.

Location
New York, NY 10111
630 5TH AVENUE
Data & Methodology

SEC EDGAR submissions API (identity, collected Sep 19, 2026, 15:11 UTC) and SEC XBRL Company Facts API (financials, collected Sep 26, 2026, 15:43 UTC) · figures as originally filed, not restated · a dash always means a value wasn't reported, never a real zero.

← Back to New York — Public Companies